NewslettersPancreatic Cell NewsUncategorizedAn Exosome-Mimicking Membrane Hybrid Nanoplatform for Targeted Treatment toward Kras-Mutant Pancreatic CarcinomaBy Justin.choi - July 13, 2021013Scientists constructed a hybrid nanoplatform by fusing Celastrol-Loaded PEGylated lipids with the DC2.4 cell membrane to achieve targeted treatment of Kras-mutant pancreatic cancer.[Biomaterials Science] 6445212 3XWAU9QG items 1 apa 0 default asc 1 164506 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract